Mizuho Maintains Outperform on Verastem, Lowers Price Target to $13

Benzinga · 3d ago
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $14 to $13.